ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Possible Government Shutdown Looms Over Biomedical Research Funding Once More

September 23, 2011

Hawaii Gets CBCCP Award

August 12, 1977

Decade-Long Cover-up?

January 6, 1995

Institute of Medicine Elects 80 New Members

October 24, 2014

Rhoads Presses For Greater Emphasis On Etiology In DNCP; Workshops Develop New Research Leads

July 16, 1976

In Brief: NCI Awards 4 Contracts For Enrichment Program; Dana-Farber Names Breast Center Leadership

July 10, 1992